ACN Newswire

Radisson Announces Exercise of Warrants

Rouyn-Noranda, Quebec--(ACN Newswire via SeaPRwire.com - November 17, 2025) - Radisson Mining Resources Inc. (TSXV: RDS) (OTCQX: RMRDF) ("Radisson" or the "Company") is pleased to announce that it has received total gross proceeds of C$1,481,694.12 from the exercise of 5,487,756 class A shares purchase warrants (the "Warrants") at a price of $0.27 per warrant. The Warrants were issued in relation to a private placement completed in November 2023 and had an expiry of November 17, 2025.Furthermore, the Company has received additional total gross proceeds of C$42,126.72 from the early exercise of 113,856 class A shares purchase warrants (the "Warrants") at a price of $0.37 per warrant. The warrants were issued in relation to a private placement completed in October 2024.Matt Manson, President and CEO, commented: "The exercise of these warrants, held by long-standing and supportive shareholders, further strengthens Radisson's financial position and supports the Company's ongoing growth initiatives. At the end of October, our treasury stood at approximately C$36 million, fully funding our ongoing 140,000 metre step out drill program at the O'Brien Gold Project."As of today, 5,430,431 warrants remain outstanding at an exercise price of $0.37, with expiry dates ranging from October 22, 2026, to October 29, 2026. If fully exercised, these warrants represent potential gross proceeds of C$2,009,259.47. No warrants were issued in connection with the Company's C$12 million private placement, completed in May 2025, nor in the most recent C$25 million private placement, completed in October 2025.Radisson Mining Resources Inc.Radisson is a gold exploration company focused on its 100% owned O'Brien Gold Project, located in the Bousquet-Cadillac mining camp along the world-renowned Larder-Lake-Cadillac Break in Abitibi, Québec. A July 2025 Preliminary Economic Assessment described a low cost and high value project with an 11-year mine life and significant upside potential based on the use of existing regional infrastructure. Indicated Mineral Resources are estimated at 0.58 million ounces (2.20 million tonnes at 8.2 g/t Au), with additional Inferred Mineral Resources estimated at 0.93 million ounces (6.67 million tonnes at 4.4 g/t Au). Please see the NI 43-101 "O'Brien Gold Project Technical Report and Preliminary Economic Assessment, Québec, Canada" effective June 27, 2025, and other filings made with Canadian securities regulatory authorities available at www.sedarplus.ca for further details and assumptions relating to the O'Brien Gold Project.For more information on Radisson, visit our website at www.radissonmining.com or contact:Matt MansonPresident and CEO416.618.5885mmanson@radissonmining.comKristina PillonManager, Investor Relations604.908.1695kpillon@radissonmining.comForward-Looking StatementsThis news release contains "forward-looking information" within the meaning of the applicable Canadian securities legislation that is based on expectations, estimates, projections, and interpretations as at the date of this news release. Forward-looking statements including, but are not limited to, statements with respect to the ability to execute the Company's plans relating to the O'Brien Gold Project as set out in the Preliminary Economic Assessment; the Company's ability to complete its planned exploration and development programs; the absence of adverse conditions at the O'Brien Gold Project; the absence of unforeseen operational delays; the absence of material delays in obtaining necessary permits; the price of gold remaining at levels that render the O'Brien Gold Project profitable; the Company's ability to continue raising necessary capital to finance its operations; the ability to realize on the mineral resource and mineral reserve estimates; assumptions regarding present and future business strategies; local and global geopolitical and economic conditions and the environment in which the Company operates and will operate in the future; planned and ongoing drilling; the significance of drill results; the ability to continue drilling; the impact of drilling on the definition of any resource; and the ability to incorporate new drilling in an updated technical report and resource modelling; the Company's ability to grow the O'Brien Gold Project; and the ability to convert inferred mineral resources to indicated mineral resources. Any statement that involves discussions with respect to predictions, expectations, interpretations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "interpreted", "management's view", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. Except for statements of historical fact relating to the Company, certain information contained herein constitutes forward-looking statements Forward-looking information is based on estimates of management of the Company, at the time it was made, involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the companies to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Such factors include, among others; the risk that the O'Brien Gold Project will never reach the production stage (including due to a lack of financing); the Company's capital requirements and access to funding; changes in legislation, regulations and accounting standards to which the Company is subject, including environmental, health and safety standards, and the impact of such legislation, regulations and standards on the Company's activities; price volatility and availability of commodities; instability in the global financial system; the effects of high inflation, such as higher commodity prices; the risk of any future litigation against the Company; changes in project parameters and/or economic assessments as plans continue to be refined; the risk that actual costs may exceed estimated costs; geological, mining and exploration technical problems; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; risks relating to the drill results at O'Brien; the significance of drill results; and the ability of drill results to accurately predict mineralization. Although the forward-looking information contained in this news release is based upon what management believes, or believed at the time, to be reasonable assumptions, the parties cannot assure shareholders and prospective purchasers of securities that actual results will be consistent with such forward-looking information, as there may be other factors that cause results not to be as anticipated, estimated or intended, and neither the Company nor any other person assumes responsibility for the accuracy and completeness of any such forward-looking information. The Company believes that this forward-looking information is based on reasonable assumptions, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this press release should not be unduly relied upon. The Company does not undertake, and assumes no obligation, to update or revise any such forward-looking statements or forward-looking information contained herein to reflect new events or circumstances, except as may be required by law. These statements speak only as of the date of this news release.Please refer to the "Risks and Uncertainties Related to Exploration" and the "Risks Related to Financing and Development" sections of the Company's Management's Discussion and Analysis dated April 29, 2025 for the year ended December 31, 2024, and the Company's Management's Discussion and Analysis dated August 27, 2025 for the three-month period ended June 30, 2025, all of which are available electronically on SEDAR+ at www.sedarplus.ca. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274899 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Latest News

教皇利奥十四世谴责非洲国家最新平民大屠杀下的基督徒迫害

(SeaPRwire) -   教皇谴责了刚果民主共和国（DRC）境内针对基督徒的最新袭击，呼吁关注他所描述的全球范围内针对信徒的日益增长的暴力模式。“在世界各地，基督徒遭受歧视和迫害。我特别想到孟加拉国、尼日利亚、莫桑比克、苏丹以及其他我们经常听到社区和礼拜场所遭到袭击的国家。……我为刚果民主共和国基伍的家庭祈祷，那里最近发生了一场平民大屠杀。让我们祈祷所有暴力停止，信徒们能为共同利益而共同努力，”教皇在一份发布在他的（）上的声明中写道。他的信息发布之际，刚果民主共和国当局证实，据The Associated Press报道，至少有17人被杀。此次袭击发生时，来自一个名为“民主同盟军”（Allied Democratic Forces）的武装组织战士袭击了位于北基伍Byambwe村的一所教会医院。袭击者于周五深夜进入教区医疗中心，杀害了病床上的病人并纵火焚烧了该设施。当地行政长官Alain Kiwewa上校告诉The Associated Press， “正在哺乳的妇女遭到残酷屠杀，被发现喉咙被割断在她们的病床上，”他补充说，有11名妇女和6名男子被杀。Vatican News 将现场描述为“对平民的恐怖袭击”，引用了幸存者和神职人员的叙述。意大利传教士Giovanni Piumatti神父，曾在Butembo-Beni教区服务五十多年，他告诉该刊物，武装分子抢劫了医疗用品，纵火焚烧了医院，并摧毁了附近27所房屋。“这是一场（屠杀），”他在Vatican News采访中说道。他补充说，民主同盟军（ADF）战士“杀害正在哺乳的母亲和她们的婴儿”，形容这是一种在该地区已变得普遍的残暴模式。民主同盟军（ADF）于2019年向伊斯兰国（Islamic State）宣誓效忠，屡次袭击刚果东部的基督徒、教堂和宗教设施。2025年8月6日Human Rights Watch的一份报告称，民主同盟军（Allied Democratic Forces）“在伊图里省Komanda的一次夜间教堂聚会中，用枪支和砍刀杀害了40多人，其中包括数名儿童”，并指出近年来该组织“被指控在刚果东部制造了大量杀戮和绑架事件”。Vatican News报道称，该医院由呈圣小修女会（Little Sisters of the Presentation）运营，该修女会在医疗设施匮乏的地区提供产妇护理和基本外科服务。据The Associated Press报道，据信有数名新生儿在袭击中被绑架。Piumatti谴责了国际社会“可耻的沉默”，称北基伍矿产丰富的地区经济利益使得武装团体得以猖獗。Byambwe大屠杀是该大陆一系列与伊斯兰主义者有关的最新袭击事件，使教皇呼吁全球关注（对基督徒的迫害）并保护脆弱社区的呼声变得更加紧迫。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

JCN Newswire

Mazda Begins Demonstration Experiment of Onboard CO2 Capture System

HIROSHIMA, Japan, Nov 17, 2025 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation today announced that it has begun demonstration experiments of Mazda Mobile Carbon Capture, Mazda's unique CO2 capture system, in support of the theme, "The Joy of Driving Fuels a Sustainable Tomorrow," announced at the JAPAN MOBILITY SHOW 2025.Demonstration ExperimentCO2 capture device installed on the demonstration vehicle(Taken from the rear lower section of the vehicle)Mazda aims to realize mobility where “driving more leads to CO2 reduction” by 2035. Mazda believes that if its vehicles run on carbon-neutral fuel and capture the CO2 emitted, it will be possible to reduce the amount of CO2 in the atmosphere in proportion to the distance traveled.In the Super Taikyu Series Round 7* held on November 15 and 16, the ‘Mazda Mobile Carbon Capture’ was installed in the "MAZDA SPIRIT RACING 3 Future Concept (Car No.55)," a race vehicle, for the first time. The vehicle ran on biodiesel fuel (HVO), a carbon-neutral fuel that has been put to practical use in Europe. The device uses zeolite with a porous structure as a CO2 adsorbent and demonstrated that it can adsorb CO2 in exhaust gas.Mazda will continue demonstration experiments in the Super Taikyu Series next season to increase CO2 recovery rates. Building on insights gained, Mazda will advance its technology and equipment, contributing to the realization of a sustainable mobility society.Related information: Mazda's corporate websiteMAZDA MIRAI BASE- JAPAN MOBILITY SHOW 2025 "The Joy of Driving Fuels a Sustainable Tomorrow ," Mazda's Vision for the Future of Mobility in 2035”https://www.mazda.com/ja/mazda-mirai-base/articles/20251029-jms2025-concept/- JMS 2025 "Does driving more make the planet cleaner MAZDA VISION X-COUPE envisions the driving pleasure of the future”https://www.mazda.com/ja/mazda-mirai-base/articles/20251029-jms2025-mazda-vision-xcoupe/MAZDA SPIRIT RACING- Super Taikyu Series: One of the most popular endurance racing series in Japan, featuring a wide range of car models:https://www.mazda.com/ja/experience/mspr/motorsports/supertaikyu/* ENEOS Super Taikyu Series 2025 Empowered by BRIDGESTONE Round 7 Super Taikyu Final Grand Thanksgiving Party  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

JCN Newswire

Pushing Hydrogen Engine Technology to New Heights in the Super Taikyu Series Final Race

Toyota City, Japan, Nov 17, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) will further advance two hydrogen engine technologies at the ENEOS Super Taikyu Series 2025 Empowered by BRIDGESTONE Round 7 Super Taikyu Final Thanksgiving Festival, to be held from November 15 to 16.The race will feature the #32 TGRR GR Corolla H2 concept (hereinafter the "liquid hydrogen-powered GR Corolla"), which runs on liquid hydrogen fuel.In addition, Toyota is continuously advancing superconductivity technology development to further evolve liquid hydrogen technology, now reaching the stage where vehicles equipped with superconducting motors for liquid hydrogen pumps can operate. We will continue development alongside our partners, aiming to compete in future races.Toyota will continue moving forward to provide customers around the world with a range of options under its multi-pathway strategy toward achieving carbon neutrality.Additionally, in conjunction with the Japan-U.S. automotive cultural exchange event organized by the Automobile Business & Culture Association of Japan, vehicles produced in the United States will be displayed in the event plaza during the race period. By providing an opportunity for visitors to experience the appeal of U.S.-market vehicles, Toyota will contribute to the exchange of automotive culture between Japan and the United States.Liquid hydrogen-powered GR CorollaAdvancing Liquid Hydrogen-Powered Engine TechnologyThe liquid hydrogen-powered GR Corolla achieved significant progress during the ENEOS Super Taikyu Series 2025 Empowered by BRIDGESTONE Round 3 NAPAC Fuji 24 Hours Race, held from May 30 to June 1. These included enhanced safety and weight reduction through the introduction of a new filling valve, and the successful demonstration of a hydrogen engine combustion switching technology. The greatest achievement was completing the race without replacing the pump that pressurizes liquid hydrogen for delivery to the engine, confirming improved durability.However, increased engine output continued to place a greater load on the pump, presenting durability challenges for continuous operation at maximum output. To reach the next level, Toyota will continue conducting test runs to verify the pump's boost performance and durability even after the 24 Hours Race. In this race, Toyota aims to achieve continuous operation at maximum output.Toyota is also continuing to develop superconductivity technology to expand the potential of liquid hydrogen technology, and has reached the stage where vehicles can run with a superconducting pump installed inside the fuel tank. Installing a highly efficient, compact superconducting motor inside the tank creates space that can help achieve more than a 1.3-fold increase in tank capacity, leading to improved cruising range. Additionally, improvements in driving performance through reduced weight and a lower center of gravity, as well as a reduction in boil-off*1 volume by eliminating the flange*2 as a heat input source, can be expected.The -253°C environment unique to liquid hydrogen provides an ideal temperature range for superconductivity, where certain materials lose all electrical resistance when cooled to extremely low temperatures. By maximizing the compatibility between liquid hydrogen vehicles and superconductivity technology, Toyota will greatly expand the potential of hydrogen engine vehicles.*1When liquid hydrogen fuel stored in the tank vaporizes due to natural heat ingress from outside*2Components that fill gaps in pipe joints to prevent leaks Exhibiting U.S.-Produced VehiclesIn conjunction with the Japan-U.S. automotive cultural exchange event featuring NASCAR driving sessions hosted by the Automobile Business & Culture Association of Japan, Toyota will display three models popular with many customers in the U.S. at the event plaza on both days, Saturday, November 15 and Sunday, November 16: the Camry sedan, the Highlander SUV, and the Tundra pickup truck. Visitors will be able to see and ride in these vehicles to experience the appeal of U.S.-produced models not sold in Japan.For related releases issued by the Automobile Business & Culture Association of Japan, Super Taikyu Mirai Organization, and Fuji Speedway, please see the following:- Automobile Business & Culture Association of Japan"Making Cars Part of Culture" - Hosting Japan-U.S. Automotive Culture Exchange Event - NASCAR Demonstration Run at Super Taikyu Final Round Fuji- Super Taikyu Mirai Organization (STMO)A New Bridge for Japan-U.S. Motorsports Exchange - Plans to Establish New "ST-USA" Class- Fuji International Speedway Co.,Ltd.NASCAR Comes to Fuji Speedway! - Jimmie Johnson Visits Japan! Japan-U.S. Stars Gather for "Super Taikyu Final Thanksgiving Festival""Achieving zero, and adding new value beyond it"As part of efforts to pass our beautiful "Home Planet" to the next generation, Toyota has identified and is helping to solve issues faced by individuals and overall society, which Toyota calls "Achieving Zero," hoping to help reduce the negative impacts caused by these issues to people and the environment to zero. Additionally, Toyota is also looking "Beyond Zero" to create and provide greater value by continuing to diligently seek ways to improve lives and society for the future.About Beyond Zero: https://global.toyota/en/mobility/beyond-zero/Toyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations' Sustainable Development Goals to help realize an ever-better world, where everyone is free to move.SDGs Initiatives: https://global.toyota/en/sustainability/sdgs/  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Latest News

德国大屠杀相关物品拍卖在强烈抗议声中取消

(SeaPRwire) -   波兰外交部长拉多斯瓦夫·西科尔斯基宣布，与大屠杀有关的物品拍卖已被取消。原计划的拍卖与德国的Felzmann拍卖行有关。西科尔斯基在X平台的一篇帖子中写道（根据翻译）：“我与德国外交部长@JoWadephul讨论了在诺伊斯举行的、关于二战期间德国恐怖时期物品的拍卖计划。我们一致认为，必须阻止这种丑闻。”他在一篇英文帖子中写道：“感谢@JoWadephul部长告知，冒犯性的大屠杀文物拍卖现已取消。尊重受害者需要庄严的沉默，而不是商业的喧嚣。”纳粹在二战期间对犹太人进行的可怕的大规模谋杀是20世纪世界历史上的一个重要事件。据美联社援引德国新闻社dpa报道，拍卖品包括集中营囚犯写的信件，以及盖世太保索引卡和其他犯罪者文件。此前已经出现了对该拍卖计划的抵制。例如，Fritz Bauer Institute在一份新闻稿中强烈反对这次拍卖。一份德语新闻稿（根据翻译）宣称：“Fritz Bauer Institute抗议Felzmann拍卖行计划举行的拍卖，并从根本上反对任何与纳粹迫害和大屠杀有关的文件的商业交易。不应利用此类文件进行任何交易。”据美联社报道，国际奥斯威辛委员会的克里斯托夫·霍伊布纳在一份声明中表示：“对于纳粹迫害的受害者和大屠杀幸存者来说，这次拍卖是一种愤世嫉俗和无耻的行为，让他们感到愤怒和无语。”据该媒体报道，他还在声明中指出：“我们敦促Felzmann拍卖行的负责人表现出一些基本的体面，并取消这次拍卖。”本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

JCN Newswire

Fujitsu launches business creation lab in collaboration with AWS Japan

KAWASAKI, Japan, Nov 17, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the launch of a business creation lab in collaboration with Amazon Web Services Japan (AWS Japan). This Lab, established as part of its global strategic collaboration agreement with AWS, integrates Fujitsu's deep industry knowledge and technology solutions with AWS's generative AI and cloud services. It will help customers in Japan’s retail and service industries to solve their management challenges faster and achieve both legacy system modernization and new revenue creation. It will facilitate business transformation that has a direct impact on management key performance indicators (KPIs) by providing end-to-end support, from identifying and defining on-site issues to rapid proof of concept (PoC) and implementation within a minimum of 90 days.Building on its achievements in the food distribution industry, Fujitsu plans to expand the lab's initiatives to other industries in Japan beyond retail and service, using AWS’s cloud and generative AI, and cross-industry data collaboration. This will contribute to customers' sustainable growth and the creation of new revenue models.The business creation lab will see close collaboration between Fujitsu's retail and service industry specialists and AWS Japan's solution architects. Key activities include:1. Problem identification and solution clarificationOn-site engagement with customers to visualize latent issues and designing solutions utilizing the latest AWS technologies.2. Rapid PoC and agile developmentProviding effective solutions by supporting customers from PoC to implementation decision within a minimum of 90 days.3. Solution and horizontal deploymentCombining Fujitsu's extensive industry knowledge and track record with AWS's extensive cloud services portfolio to standardize solutions. This enables the phased provision of services, from legacy systems (mainframes, EDI, etc.) to API integration, contributing to solving diverse challenges across various industries, including food distribution, retail, trading companies, food manufacturers, and other service sectors.Tomohiko Sugimoto, General Manager of Information Systems Division, Mitsubishi Shokuhin Co., Ltd. comments:"At Mitsubishi Shokuhin, we are addressing the critical challenge of transferring expert knowledge in our inter-company EDI project as part of our AI utilization strategy. We decided to adopt this approach, combining the technologies and expertise of Fujitsu and AWS Japan, as it enables a highly effective method of knowledge standardization through generative AI chatbots. This initiative will further accelerate the standardization and automation of manual tasks, and we envision its expansion into more advanced areas, such as preventing system troubles. We look forward to continuing our strong partnership with both companies to co-create new value."Hiroyuki Tsutsumi, Director, Enterprise Business Unit, Amazon Web Services Japan G.K. comments:"With the establishment of the 'business creation lab,' I am confident that the fusion of Fujitsu's deep industry knowledge and AWS's latest technologies, including generative AI, will further accelerate and promote innovation not only in the retail and service industries but throughout Japan. Building on our history of supporting Japanese customers' business transformation together, we look forward to continuing to transform businesses across Japan through our ongoing collaboration with Fujitsu."Yoshiko Furuhama, Corporate Executive Officer EVP, in charge of Enterprise Business, Fujitsu Limited comments:"This lab will serve as a hub for reflecting customers' on-site challenges in their management strategies and leveraging Fujitsu’s extensive knowledge and technology to create new business value. Fujitsu has a long history of advancing innovative initiatives with customers in the retail and service industries. Through this lab, we will apply this knowledge and experience in collaboration with our long-standing partner, AWS Japan. Our goal is to support customers swiftly from concept formulation to verification and implementation, ensuring that technology and AI utilization go beyond mere system deployment to solve their challenges and enhance corporate value. Together with our customers, we aim to contribute to sustainable growth and strengthen industrial competitiveness."Fujitsu and AWS Japan have previously collaborated to address customer challenges by combining their respective strengths. This initiative further deepens this collaboration for Japan's retail and service industries. Leveraging insights gained from past successes, such as resolving knowledge transfer issues for legacy system experts at Mitsubishi Shokuhin Co., Ltd. through generative AI-driven knowledge standardization, the lab aims to create business value and accelerate industry-wide transformation.Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

JCN Newswire

NTT DOCOMO Achieves Successful Outdoor Trial of AI-Driven Wireless Interface Toward 6G

TOKYO, Japan, Nov 17, 2025 - (JCN Newswire via SeaPRwire.com) - NTT DOCOMO, INC. announced today that they have successfully conducted the world’s first outdoor demonstration using real-time transceiver systems with AI-powered wireless technology for sixth-generation (6G) mobile communications. The demonstration was carried out in collaboration with NTT, Inc. (“NTT”), Nokia Bell Labs., and SK Telecom Co., Ltd. (“SK Telecom”). Field trials took place at three locations in Yokosuka City, Kanagawa Prefecture, and confirmed that the use of AI improved throughput (transmission speed) by up to 100% compared with conventional non-AI-based methods under the same environmental conditions, effectively doubling the communication speed.In wireless communications, fluctuations in the radio propagation environment can cause unstable connection quality. To address this issue, the parties have been developing and testing “AI-AI technology,” which applies artificial intelligence to both the transmitting and receiving sides of the wireless interface to optimize modulation and demodulation schemes according to radio conditions, enabling stable communication across diverse use cases. The effectiveness of this technology had previously been verified in indoor environments.(*1)The latest field trials aimed to verify whether this new technology can maintain stable performance in outdoor environments, where radio conditions vary greatly due to temperature, weather, and obstacles.In the field trials, DOCOMO and its partners evaluated the AI-AI technology under three outdoor environments with varying radio propagation conditions, such as the presence of obstacles and whether the terminal was stationary or in motion. The evaluations were conducted using devices equipped with the technology to compare throughput performance with and without its application.Course 1: A public road with gentle curves where the test vehicle traveled at speeds of up to 40 km/hCourse 2: An environment with partial obstaclesCourse 3: A road with few obstacles where the test vehicle traveled at speeds of up to 60 km/hThe results confirmed that applying the AI-AI technology improved communication speed by compensating for signal degradation across all test environments. In particular, under the most complex propagation conditions in Course 1, the technology achieved an average through put improvement of 18% and a maximum of 100% compared to conventional methods. This improvement enables users to transmit larger volumes of data at higher speeds, while also allowing network operators to enhance spectrum efficiency and deliver higher-quality communication services.These findings demonstrate that the AI-AI technology is effective not only indoors but also in complex outdoor environments, marking a significant step toward practical 6G systems that combine high wireless transmission efficiency with low power consumption.DOCOMO will continue to refine this technology under diverse conditions and accelerate R&D toward 6G realization, while also collaborating with global partners to advance 6G standardization and implementation.This technology will be showcased at the NTT R&D FORUM 2025, hosted by NTT from November 19–21 and November 25–26, 2025. Further details on the official event website: https://www.rd.ntt/e/forum/2025/(*1) 6G Radio-interface Indoor Test Using AI in the 4.8 GHz Band for the First Time in Japan Improves Throughput up to 18% (November 20, 2024)About NTT DOCOMONTT DOCOMO, Japan's leading mobile operator with over 91 million subscribers, is one of the global leaders in 3G, 4G and 5G mobile network technologies. Under the slogan “Bridging Worlds for Wonder & Happiness,” DOCOMO is actively collaborating with global partners to expand its business scope from mobile services to comprehensive solutions, aiming to deliver unsurpassed value and drive innovation in technology and communications, ultimately to support positive change and advancement in global society. https://www.docomo.ne.jp/english/For more details, please visit: https://www.docomo.ne.jp/english/info/media_center/pr/2025/1117_00.html  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

ACN Newswire

Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions

SUNNYVALE, CA, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - Graid Technology today announced the successful completion of its agreement with Intel Corporation to license the rights to market, sell, and develop Intel® Virtual RAID on CPU (Intel® VROC). The successful completion of this transaction marks a significant milestone that accelerates Graid Technology's progress toward profitable growth and delivering on its vision for the future of enterprise storage.Graid Technology Finalizes Intel® VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions"This agreement represents an exciting new chapter for Graid Technology and for the global ecosystem that relies on Intel® VROC," said Leander Yu, CEO of Graid Technology. "Finalizing the deal allows us to ensure long term continuity for existing customers while also accelerating innovation and value creation across the enterprise storage market."Since the initial announcement, Graid Technology has engaged in productive discussions with many VROC customers, OEMs, and channel partners who have expressed strong support and enthusiasm for the transition."Customer response has been overwhelmingly positive," added Thomas Paquette, Sr. Vice President and GM, Americas & EMEA at Graid Technology. "Partners and system builders see this transition as a win win; protecting their current investments in Intel® VROC while benefiting from Graid Technology's focus, agility, and commitment to high performance storage innovation."Under the terms of the agreement, Graid Technology has assumed responsibility for Intel® VROC customer support and development pipeline, ensuring uninterrupted service and expanding collaboration opportunities across new storage and data infrastructure markets. At this time, Graid Technology has not established a roadmap for new feature enhancements to Intel® VROC, but the team is actively listening to customer feedback and prioritizing their ongoing needs.For more information about Intel® VROC and Graid Technology's enterprise storage solutions, visit https://graidtech.com/vroc.Media Inquiries:Andrea EakenGraid Technology Sr. Director of Marketing, Americas & EMEAandrea.eaken@graidtech.comContact InformationAndrea EakenSenior Director of Marketing, Americas & EMEAandrea.eaken@graidtech.com949-742-9928SOURCE: Graid Technology Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

JBM Healthcare Announces FY2026 Interim Results

KEY HIGHLIGHTS-  Revenue increased 7.7% year-on-year to HK$429.6 million-  Gross profit rose 23.2% to HK$253.6 million-  Profit attributable to equity shareholders increased 20.0% to HK$115.0 million-  Declared an interim dividend of HK9.75 cents per share-  Ho Chai Kung and Po Chai Pills achieved steady growth supported by strong marketing and brand execution- Cross-border e-commerce and concentrated Chinese medicine granules (CCMG) businesses remained resilient and contributed to stable performanceHONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – JBM (Healthcare) Limited (“JBM Healthcare” or the “Company”, Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, today announced its interim results for the six months ended 30 September 2025 (“FY2026 Interim” or the “Reporting Period”).Despite a challenging retail environment, JBM Healthcare delivered moderate growth, with revenue increasing by 7.7% to HK$429.6 million and profit attributable to equity shareholders rising by 20.0% to HK$115.0 million during the Reporting Period. The solid performance was underpinned by the strength of its flagship proprietary brands, diversified product portfolio, and disciplined execution. The Group continued to enhance brand equity and expand market reach through integrated marketing, e-commerce expansion, and strategic engagement initiatives across Hong Kong and the Greater Bay Area.Resilient Performance across Core SegmentsDuring the Reporting Period, the Branded Medicines segment achieved solid growth, led by the sustained momentum of Ho Chai Kung. Building on its reputation as a trusted over-the-counter remedy for pain and fever, the brand further strengthened its market presence through a series of high-impact marketing initiatives.Television advertising featuring brand ambassador Hins Cheung enhanced brand awareness and consumer engagement, while strategic sponsorships and event partnerships broadened audience reach. The brand also gained strong visibility through its participation in large-scale televised events, effectively connecting with both middle-aged and younger consumers.The Proprietary Chinese Medicines segment recorded notable growth, led by Po Chai Pills and supported by the CCMG business.During the period, Po Chai Pills launched its innovative “tear-and-take” sachet pack designed for convenient, on-the-go use. A lively TV commercial featuring Louis Koo, Tony Wu , and Bonnie Wong captured strong public attention, blending nostalgic charm with modern visuals and achieving millions of online views within weeks of launch, adding momentum for the brand. Complemented by community campaigns, youth outreach, and large-scale outdoor visibility, these initiatives further strengthened Po Chai Pills’ relevance across generations.The Health and Wellness Products segment recorded a moderate decline due to the rationalisation of certain products, partially offset by the solid and steady growth of the Oncotype DX Breast Cancer Recurrence Score Test. The test’s adoption continued to expand in both Hong Kong and Macau. Supported by ongoing collaboration with the Hong Kong Breast Cancer Foundation, the Group further advanced public education on genomic testing and precision medicine, reinforcing Oncotype DX’s position as a trusted diagnostic assay test that provides individualised data on tumor biology , helping doctors tailor a treatment plan specifically to the individual, ensuring appropriate therapy and increasing confidence in treatment decisions.  Expanding E-Commerce and TCM Market OpportunitiesDuring the Reporting Period, the Group further expanded its presence across leading cross-border e-commerce platforms such as Tmall Global, JD.com, and Alibaba Health. Ho Chai Kung and Po Chai Pills continued to perform strongly online. These efforts enhanced brand awareness, customer perceptions and product acceptance amongst the target prospects in Chinese MainlandIn the traditional Chinese medicine (TCM) market, the Group maintained stable performance in its CCMG business, supplying over 700 single- and combo-formula granules to a wide network of registered practitioners. To capture new market opportunities, JBM Healthcare is expanding its TCM portfolio with new products and an upgraded e-business platform designed to streamline ordering processes, enhance practitioner engagement, and integrate online and offline service experiences.Mr. Derek Sum, Executive Director of JBM Healthcare, commented, “Amid a challenging market, we sustained growth through disciplined execution and the continued strength of our flagship brands. Our diversified portfolio and expanding e-commerce footprint have reinforced JBM Healthcare’s resilience and competitiveness. Looking ahead, we will continue to enrich our product mix, deepen customer engagement, and capture opportunities across Hong Kong, the Greater Bay Area, and other key markets to deliver sustainable long-term value.”About JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Tin Hee Tong Tin Hee Pills, Contractubex, Tong Tai Chung Woodlok Oil , Flying Eagle Woodlok Oil , Saplingtan , Shiling Oil and Konsodona Medicated Oil . JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hkFor media inquiries, please contact:Strategic Financial Relations LimitedVicky LeeTel: (852) 2864 4834Email: vicky.lee@sprg.com.hkRachel KoTel: (852) 2114 2370Email: rachel.ko@sprg.com.hkCoco YuTel: (852) 2864 4876Email: coco.yu@sprg.com.hk Fax: (852) 2527 1196 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

健倍苗苗公布二零二六财政年度中期业绩

业绩亮点- 收益按年增长7.7%至4.3亿港元- 毛利上升23.2%至2.5亿港元- 股东应占溢利上升20.0%至1.15亿港元- 宣派中期股息每股9.75港仙- 旗舰品牌何济公及保济丸在高效的市场推广及品牌执行策略带动下持续稳健增长- 跨境电商及中药配方颗粒业务保持稳定，为整体表现作出贡献香港, 2025年11月17日 - (亚太商訊) - 健倍苗苗（保健）有限公司（「健倍苗苗」或「本公司」，股份代号：2161，连同其附属公司统称「集团」），作为香港领先的品牌保健产品市场推广及分销商，今日公布截至二零二五年九月三十日止六个月（「二零二六财年中期」或「报告期」）之中期业绩。尽管零售环境仍具挑战，集团于报告期内录得稳健增长，收益上升7.7%至4.3亿港元，股东应占溢利上升20.0%至1.15亿港元。业绩表现主要受惠于旗下旗舰自主品牌的持续动力、多元化产品组合以及严谨的执行力。集团继续透过综合市场推广、电子商贸拓展及策略性互动合作，进一步强化品牌资产并扩展于香港及大湾区的市场覆盖。业务板块表现稳健报告期内，品牌药业务录得稳定增长，主要由于旗舰品牌何济公的持续动力带动。凭借其作为家传户晓的止痛退烧良药的信誉，品牌透过一系列具影响力的市场推广活动强化市场地位。由品牌代言人张敬轩先生演出的电视广告提升了品牌知名度与强化了消费者互动，而策略性的赞助与活动合作则扩大了受众覆盖范围。该品牌亦通过赞助知名电视节目获得了高度曝光，有效触及中高龄与年轻消费者群体。品牌中药业务表现同样理想，由保济丸的出色增长带动，并受中药配方颗粒业务的稳定贡献支持。报告期内，保济丸推出全新「条装版」包装，「一撕即食」，即撕开包装便可服用，为消费者带来便携便利的新体验。由古天乐先生带领、加上胡子彤先生及黄正宜小姐演出的广告，以轻松幽默的手法展现产品特色，融合怀旧与现代视觉美感，上线短短数周即录得数百万观看次数，进一步巩固品牌动力。品牌并透过校园互动活动、小区文化展览及大型户外广告，加强跨世代的市场渗透及消费者共鸣。健康及保健产品业务录得温和下跌，主要由于对部分产品进行整合，但Oncotype DX乳癌复发基因检测持续稳健增长，并抵销部分跌幅。该检测于香港及澳门的应用持续扩大。在与香港乳癌基金会的持续合作支持下，集团进一步推广基因组检测及精准医疗的公众教育，巩固Oncotype DX作为可靠诊断检测的地位。此检测能提供肿瘤生物学的个体化数据，协助医生制定专属的治疗方案，确保患者获得适切治疗，并提升治疗决策的信心。拓展电商版图及中医药市场机遇报告期内，集团进一步扩展于跨境电商平台的布局，包括天猫国际、京东及阿里健康等主要电商渠道。何济公及保济丸在在线渠道表现持续强劲。这些举措有效提升了中国内地目标潜在客户对品牌的认知度、好感度及对产品接受程度。于中医药市场方面，集团的中药配方颗粒业务维持稳定表现，为香港超过700名注册中医师提供单方及复方颗粒产品，凭借稳定质量与可靠供应获业界广泛信任。为进一步扩大市场覆盖，集团正积极开发新产品并推出升级版电子商贸平台，以提升订单流程效率、强化与中医师及诊所的互动，并整合在线线下服务体验，推动业务长远增长。健倍苗苗执行董事岑广业先生表示：「在具挑战的市场环境下，我们凭借审慎执行力与品牌实力，持续录得稳健增长。凭借多元化的产品组合与日益扩大的电商版图，我们的韧性与市场竞争力得到进一步提升。展望未来，我们将丰富产品组合、深化客户互动，并把握香港及大湾区以至其他重点市场的机遇，为持份者缔造可持续的长期价值。」有关健倍苗苗（保健）有限公司 （股份代号：2161）健倍苗苗是设于香港的品牌医疗保健品推广及分销公司，产品据点遍及大中华、东南亚及其他选定国家。集团拥有丰富的营销专业知识并具备深厚的制药背景，秉承产品功效和质量至上的优良传统，在行业内定位独特，致力于满足消费者的保健需要。作为本地领先的品牌医疗保健品运营商，集团拥有一广泛系列品牌医疗保健品，包括品牌药、品牌中药及健康保健品，其中包括「保济丸」、「何济公止痛退热散」、「天喜堂天喜丸」、「德国秀碧除疤膏」、「唐太宗活络油」、「飞鹰活络油」、「十灵丹」、「十灵油」及「镇痛霸祛风活络油」等家喻户晓的传统品牌。而自2021年 5月27日，集团获纳入 MSCI 香港微型股指数成份股。有关集团详情，请浏览：www.jbmhealthcare.com.hk传媒查询：纵横财经公关顾问有限公司李惠儿电话: （852） 2864 4834电邮:  vicky.lee@sprg.com.hk高文萱电话: （852） 2114 2370电邮:  rachel.ko@sprg.com.hk余淑媛电话: （852） 2864 4876电邮:  coco.yu@sprg.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

JCN Newswire

Destinator Earns the Highest Rating of Five Stars in 2025 ASEAN NCAP

 Destinator TOKYO, Nov 17, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that its all-new Destinator midsize SUV has earned a maximum five-star rating in the 2025 ASEAN NCAP*, a comprehensive safety performance assessment program for new vehicles in the ASEAN region.Mitsubishi Motors remains committed to its vision of a mobility society with zero traffic accidents, through ongoing efforts to develop and promote safety technologies and raise awareness of traffic safety.The Destinator is equipped with the brand’s advanced driver assistance system, Mitsubishi Motors Safety Sensing. It delivers a high level of preventive safety through Adaptive Cruise Control (ACC), Forward Collision Mitigation system (FCM), Blind Spot Warning (BSW), Rear Cross Traffic Alert (RCTA), Automatic High Beam (AHB), Leading Car Departure Notification (LCDN), and Multi Around Monitor. Along with six SRS airbags, the model ensures collision safety performance with a high-rigidity body structure designed to absorb impact energy while minimizing cabin deformation in the event of a crash.As a seven-seat midsize SUV, the Destinator features a spacious three-row layout and is characterized by a refined, authentic SUV design and a premium cabin that offers comfort for everyone on board. Its 1.5-liter turbo engine, paired with a Continuously Variable Transmission (CVT) optimized for both fuel efficiency and acceleration, delivers strong, exhilarating response. Additionally, while adopting a front-wheel drive system, Mitsubishi Motors combines its advanced all-wheel control technologies, including the Active Yaw Control (AYC), to deliver safe and reliable driving across diverse road surfaces and weather conditions.Sales began in Indonesia in July 2025, and the all-new Destinator is scheduled to launch in the Philippines on November 20, followed by Vietnam by the end of 2025. Subsequent launches are planned across the ASEAN region, South Asia, Latin America, the Middle East, and Africa, with a global rollout to roughly 70 countries.*New Car Assessment Program for Southeast Asian CountriesAbout Mitsubishi MotorsMitsubishi Motors Corporation (TSE:7211) — a member of the Alliance with Renault and Nissan — is a global automobile company based in Tokyo, Japan, which has about 28,000 employees and a global footprint with production facilities in Japan and the ASEAN region. Mitsubishi Motors has a competitive edge in SUVs, pickup trucks and plug-in hybrid electric vehicles, and appeals to ambitious drivers willing to challenge convention and embrace innovation. Since the production of our first vehicle more than a century ago, Mitsubishi Motors has been a leader in electrification — launched the i-MiEV, the world’s first mass-produced electric vehicle in 2009, followed by the Outlander PHEV, the world’s first plug-in hybrid electric SUV in 2013. With a target of increasing the sales ratio of electrified vehicles to 100% by 2035, Mitsubishi Motors will deliver models that embody Mitsubishi Motors-ness and contribute to the realization of a carbon-neutral society. For more information on Mitsubishi Motors, please visit the company's website at https://www.mitsubishi-motors.com/en/  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

JCN Newswire

“LEQEMBI(R)” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom

TOKYO and CAMBRIDGE, Mass., Nov 14, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (generic name: lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom.In August 2024, LEQEMBI was approved for the treatment of mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD) in adult patients that are apolipoprotein E ε4 (ApoE ε4)* heterozygotes or non-carriers in the United Kingdom. With this latest approval for IV maintenance dosing, after 18 months of a dosing regimen of 10 mg/kg once every two weeks patients may be transitioned to the maintenance dosing regimen of 10 mg/kg once every four weeks, or the regimen of 10 mg/kg once every two weeks may be continued.AD is a progressive, relentless disease characterized by formation of protein deposits known as plaques made of amyloid-beta aggregates and neurofibrillary tangles made of tau protein in the brains of people living with AD.  It is caused by a continuous underlying neurotoxic process that begins before amyloid plaque accumulation and continues after plaque removal.1,2 The data show that amyloid-beta protofibrils and tau tangles play roles in the neurodegeneration process,2,3 and only LEQEMBI fights AD in two ways – targeting both amyloid plaque and protofibrils**, which can impact tau downstream.Due to the reaccumulation of AD biomarkers and return to placebo rate of decline after therapy is stopped,3-5 continuing maintenance treatment after the initial 18-month therapy is essential to slow the progression of AD and extend the therapeutic benefits, helping patients maintain who they are for longer.In the United Kingdom, it is estimated that 982,000 people are living with dementia,6 and AD is the cause in 60-70% of people with dementia.7 These numbers are expected to rise, as the population ages.6, 7Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.* Apolipoprotein E is a protein involved in the metabolism of lipid in humans. It is implicated in AD. People with only one (heterozygous) or no copy (non-carriers) of the ApoE ε4 gene are less likely to experience ARIA than people with two ApoE ε4 copies (homozygous).8** Protofibrils are thought to be the most toxic Aβ species that contribute to brain damage in AD and play a major role in the cognitive decline of this progressive and devastating disease. Protofibrils can cause neuronal and synaptic damage in the brain, which can subsequently adversely affect cognitive function through multiple mechanisms.3 The mechanism by which this occurs has been reported not only by increasing the formation of insoluble Aβ plaques, but also by directly damaging signaling between neurons and other cells. It is believed that reducing protofibrils may reduce neuronal damage and cognitive impairment, potentially slowing the progression of AD.4MEDIA CONTACTSEisaiEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120Eisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@eisai.comBiogen Inc.Madeleine Shin+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations DepartmentTEL: +81 (0)3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.comAbout LEQEMBI (generic name: lecanemab)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in 51 countries and is under regulatory review in 9 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks was approved in the United Kingdom, the U.S, China and others, and applications have been filed in 4 countries and regions.LEQEMBI's approvals in these countries were based on Phase 3 data from Eisai's, global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results. The primary endpoint was the global cognitive and functional scale, Clinical Dementia Rating Sum of Boxes (CDR-SB).1 The U.S. FDA approved Eisai’s Biologics License Application (BLA) for subcutaneous maintenance dosing with LEQEMBI IQLIK in August 2025. In September 2025, the rolling sBLA application to the U.S. FDA for the subcutaneous initiation dosing with LEQEMBI IQLIK was also initiated.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.For more details, please visit: https://www.eisai.com/news/2025/pdf/enews202579pdf.pdf  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

JCN Newswire

NEC Advances Research Information Infrastructure for Open Science

TOKYO, Japan, Nov 17, 2025 – NEC Corporation (NEC; TSE: 6701) has launched a new suite of solutions designed for research institutions, such as universities, to promote open science.By offering a comprehensive set of solutions that enhance competitiveness in research and development and ensure the transparency of research outcomes, NEC aims to contribute to the efficient and effective establishment of research information infrastructure (RII).In recent years, the trend towards open science, which involves sharing research data across society, has accelerated. As a result, there is a growing demand from research institutions for improved management, storage, and utilization of research data.Furthermore, as part of enhancing international research competitiveness and ensuring the transparency of research outcomes, there is a rising demand for stronger governance, including requirements for the proper management and storage of research data.In response, NEC is launching a suite of solutions that enables the efficient and effective creation of RII, from introduction to operation. Value Provided to Customers through Advanced Research Information InfrastructureContributing to Enhanced Collaboration with Research Institutions and Accelerated real world Implementation through Advanced Research Information InfrastructureNEC provides a suite of solutions for the appropriate and efficient utilization of research data throughout the entire lifecycle of research, including data generation, analysis, aggregation, management, publication, and utilization. These solutions contribute to fostering collaboration with universities and research institutions and promoting the real world implementation of research findings.Overall Concept of Research Information Infrastructure (RII)NEC offers the following solutions:- NEC Ultra-high-speed Data Transfer System This system enables efficient aggregation and sharing of large-scale research data generated by various experimental and measurement facilities and high-performance computing (HPC) simulations. It maximizes network bandwidth and achieves high-speed disk-to-disk data transfer. This solution is effective in scenarios such as sharing large-scale experimental research data, utilizing large-scale data aggregation platforms, and implementing business continuity plans (BCP).Usage Scenario of NEC Ultra-high-speed Data Transfer System- NEC Data Provenance System for HPC (*1) This system automatically collects and allows reference to provenance information, such as input/output files and program execution details, in HPC simulations. It allows easy reference to provenance information without special processing during simulation execution, and this information can also be shared with others. This solution is effective in improving research efficiency by clarifying simulation reproduction procedures and simplifying the identification of data to be saved. It is also valuable for presenting data as evidence for papers and for use in collaborative research.Usage Scenario of NEC Data Provenance System for HPC* Data Catalog and Portal System for Promoting Research Data Utilization, Including AI-driven Approaches Serving as a portal for RII, this system promotes data aggregation and facilitates data utilization by users and administrators.* Resource Pooling and Remote Resource Utilization System utilizing NEC's proprietary ExpEther (Express Ether) Technology for Reliable, Low-Latency Transmission of IT Device Signals (*2) This system enables the utilization of remote computing resources, even for sensitive data that cannot be taken off-site.NEC provides these solutions as an integrated system tailored to customer environments.Comments on this announcement are as follows:The University of Osaka D3 Center has launched operations of the Data Provenance System for HPC via the "Osaka University Compute and sTOrage Platform Urging open Science" (OCTOPUS), a computational and data platform promoting open science introduced in September 2025. Every day, supercomputers at computing centers analyze and generate vast amounts of academic data. One of the challenges facing platform providers offering computational infrastructure for academic research is how to ensure the fairness of calculations performed on computers. Since the research process and results are often recorded and managed manually by researchers, I believe that realizing transparency in the research process and implementing an efficient audit trail management system through the automation of recording of computational provenance will significantly contribute to promoting open science.- Susumu Date, Professor, Advanced High-Performance Computing Infrastructure Systems Research Division, D3 Center, The University of OsakaThe Square Kilometre Array Observatory (SKAO) is a project aimed at constructing the world’s largest radio telescope. This initiative will require transferring unprecedented volumes of observational data between data centers worldwide, which presents a significant challenge in implementing high-speed, reliable data transfer infrastructure. The ultra-high-speed data transfer system provided by NEC enables 100 Gbps-class communication between storage located in remote areas, and we are currently conducting verification testing to prepare for its introduction as an effective solution to this challenge.- Takuya Akahori, Project Researcher, Lead of the SKA1 Promotion Group, Mizusawa VLBI Observatory, National Astronomical Observatory of Japan (NAOJ), National Institutes of Natural Sciences (NINS)Event InformationExhibition booth at SC25, the world's largest international conference for HPC and AI. Date: November 16-21, 2025, Location: St. Louis, USA. Details here: https://sc25.supercomputing.org/(*1): Data Provenance System for HPC has been pre-introduced at The University of Osaka The University of Osaka D3 Center Commences Operation of New Computing and Data Infrastructure Built by NEChttps://www.nec.com/en/press/202509/global_20250912_01.html(*2: Demonstrations on the utilization of ExpEther have begun at The University of Osaka. The University of Osaka D3 Center and NEC Demonstrate Wide-Area Distributed Campus AI Processing Platformhttps://www.nec.com/en/press/202511/global_20251113_01.htmlAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

ACN Newswire

Indonesia’s TASPEN Fulfills Global Mandate, Delivering Full Benefits to Late Diplomat’s Family

JAKARTA, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - Indonesia's state-owned social security agency PT TASPEN (Persero) has reiterated its commitment to ensuring social protection for all Indonesian Civil Servants and State Officials, including those stationed abroad.President Director Taspen, Rony Hanityo (2nd left) delivers Work Accident Security Program benefits to the wife of the late Zetro Leonardo Purba, Junior Chancellery Officer at the Indonesian Embassy in Lima, Peru, who died while performing official duties on Sept 1, 2025.The statement follows TASPEN's recent distribution of Work Accident Security Program (Jaminan Kecelakaan Kerja/JKK) benefits to the family of the late Zetro Leonardo Purba, a Junior Chancellery Officer at the Indonesian Embassy in Lima, Peru, who died while performing official duties on September 1, 2025.TASPEN Corporate Secretary Henra expressed condolences to the bereaved family and underscored the agency's role in upholding the state's responsibility to protect civil servants serving anywhere in the world."TASPEN expresses its deepest condolences on the passing of Mr. Zetro Leonardo. The distribution of these benefits is proof that TASPEN carries out its state mandate with integrity and accountability. It is our responsibility to ensure that every civil servant's dedication — even at the farthest corners of the world — is accompanied by a sense of security for them and their families. The state's protection knows no borders," said Aprianto.As of September 30, 2025, TASPEN has provided JKK benefits to 221 heirs of Indonesian civil servants, including those serving on overseas assignments — a reflection of the government's continued commitment to the welfare of public sector workers worldwide.Comprehensive Protection for Civil Servants and FamiliesThe assistance provided to Mr. Purba's family includes Old-Age Savings Program (Tabungan Hari Tua/THT) and Work Accident Security Program benefits, such as Death Benefits/Bereavement Benefits, Death Compensation, and Funeral Benefit. In addition, Scholarship Benefit has been granted for two of his children to support their continued education — part of TASPEN's broader effort to ensure long-term family welfare.The Work Accident Security Program (JKK) forms part of Indonesia's national social protection framework for civil servants and state officials who experience work-related accidents, occupational illnesses, or death while performing state duties — whether domestically or abroad.Four Key Programs Supporting Civil ServantsTASPEN manages four major programs designed to create an integrated and sustainable social security system for civil servants:1. Old-Age Savings Program (THT): A savings and protection plan for employees nearing retirement or their families in case of death before retirement.2. Pension Program: Guarantees a regular post-retirement income as recognition of civil servants' long-term service.3. Work Accident Security Program (JKK): Covers the risk of workplace injuries, illnesses, or death occurring in the line of duty, including while serving abroad.4. Death Security Program (Jaminan Kematian/JKM): Provides compensation and educational scholarships for the families of civil servants who pass away from non-work-related causes.These programs establish a comprehensive social safety net that protects civil servants throughout their professional and personal lives. TASPEN's initiatives reflect the Indonesian government's principle that public service deserves lifelong protection — regardless of where it is carried out. By extending coverage beyond national boundaries, the TASPEN ensures that Indonesian civil servants serving on global missions receive the same level of welfare assurance as those at home.Through adaptive and accountable management, TASPEN continues to play a strategic role as a partner of the Indonesian government in strengthening the welfare and security of civil servants worldwide.About PT TASPEN (Persero)PT TASPEN (Persero) or the Civil Servant Savings and Insurance Fund is an Indonesian state-owned enterprise engaged in retirement savings insurance and pension funds for civil servants (ASN) and state officials. Established on April 17, 1963, PT TASPEN (Persero) plays an active role in social welfare, particularly for civil servants in Indonesia. PT TASPEN (Persero) currently offers several products and services, namely the Work Accident Security Program (JKK), Death Security Program (JKM), Old-Age Savings Program (THT), and Pension Program.PT TASPEN (Persero) is currently the First Chairman of the Asian Civil Service Pension Association (ACSPA), which is the first Association of Social Security Administrators for Civil Servants in Asia, with members consisting of Social Security Administrators for ASN from various countries in Asia, including Indonesia, South Korea, the Philippines, Thailand, and Cambodia. PT TASPEN (Persero) prioritizes the comfort and safety of its participants by implementing the digital superapp service Andal by TASPEN.For information, you can contact the Call Center at 1500919, visit the official website www.taspen.co.id, tcare.taspen.co.id, and all official social media accounts of PT TASPEN (Persero). Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

TAIPEI, TAIWAN, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology.Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma.To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to experimental therapies that have the potential to treat these diseases. In the United States, a rare disease is defined as any condition that affects fewer than 200,000 patients. After granting Orphan Drug Designation, the US FDA qualifies companies or drug developers incentives such as tax credits for clinical trials, exemption from user fees, and marketing exclusivity2.In August 2025, OBI launched a phase I/II clinical trial in the United States and Taiwan, recruiting patients with advanced solid tumors. The objectives of the trial are to study the safety, pharmacokinetics, and preliminary efficacy profile of OBI-902 in these patient populations.Heidi Wang, Ph.D, OBI Pharma's Chief Executive Officer noted, "Based on our preclinical data, OBI-902 has several important advantages over other TROP2 ADCs either approved or in development; including high stability in blood circulation, excellent bystander effect that extends the killing to neighboring cancer cells lacking TROP2 expression, potential ability to overcome drug resistance, and outstanding activity in animal and organoid models of cancer. Importantly, this marks the first time an ADC that incorporates OBI's proprietary GlycOBI® ADC technology is being evaluated in patients, including those diagnosed with cholangiocarcinoma. We look forward to investigating this potential best-in-class TROP2 ADC in the clinic."About OBI-902OBI-902 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload to kill tumor cells and with a drug-antibody ratio (DAR) of 4. TROP2 is highly expressed in a variety of solid tumors such as breast, lung, biliary, bile duct (cholangiocarcinoma), ovarian, gastric, and many other cancer types, rendering it an ideal target for cancer therapy.OBI-902 is a novel site-specific glycan-conjugated ADC using OBI's proprietary GlycOBI platform, which provides improved stability and enhanced hydrophilicity. OBI-902 demonstrated remarkable antitumor efficacy, improved pharmacokinetic characteristics, and a favorable safety profile in various animal models. The IND of OBI-902 was cleared by the US FDA on April 30, 2025.Since December 2021, OBI has been granted by Biosion, Inc. (www.biosion.com) an exclusive, worldwide (except in China) license to a TROP2 targeting antibody amino acid sequence. Biosion holds exclusive rights to that antibody sequence in China. OBI holds worldwide commercial rights to OBI-902, except for the rights pertaining to the antibody in China.About GlycOBI®OBI has developed a unique clinical stage, glycan-based site-specific ADC technology (GlycOBI®), which is in a ‘Plug and Play' format and compatible with any antibodies, linkers, and payloads in drug-antibody ratio (DAR) up to 16. Utilizing OBI's proprietary dual-function enzyme (EndoSymeOBI®) and linker technology (HYPrOBI®), homogenous ADCs are manufactured with an efficient and scalable process under GMP conditions. The conjugation process of GlycOBI® avoids disrupting the antibody structure and ensures the ADC has similar biophysical characteristics to the native antibody. Furthermore, OBI's linker technology has improved conjugation efficiency of the payload, reduced aggregation propensity, which provides advantages on manufacturing ADC products. GlycOBI® conjugated ADCs have overcome the limitations of traditional ADCs and achieved better antitumor activity and stability in various in vivo animal studies. GlycOBI®, EndoSymeOBI®, and HYPrOBI® are part of the armamentarium of OBI's Obrion™ ADC Enabling Technologies that also include ThiOBI® and GlycOBI DUO™. OBI-902 is the first ADC utilizing OBI's Obrion™ ADC enabling technology for evaluation of safety and efficacy in Cancer, currently under Phase I/II clinical trial in the US and Taiwan.About OBI PharmaOBI is a clinical stage global oncology company that is headquartered in Taiwan and established in 2002. Its mission, together with its wholly owned subsidiary OBI Pharma USA, Inc., is to develop novel therapeutic agents for patients with high unmet medical needs.OBI's primary focus is the development of novel ADCs, including the first-generation cysteine-based TROP2 ADC, OBI-992. Using the company's proprietary ADC enabling technology, GlycOBI®, powered by EndoSymeOBI® and HYPrOBI®; OBI has created its next-generation novel ADC pipeline, including monospecific: OBI-902 (TROP2), OBI-904 (Nectin-4), bispecific single payload (HER2 x TROP2), and bispecific, dual payload (cMET x HER3) ADCs. To broaden the applicability of linker technology, HYPrOBI®, OBI further developed a novel ThiOBI® platform to enable irreversible cysteine-based conjugation. Additionally, OBI's pipeline includes the first-in-class AKR1C3-targeted small-molecule prodrug OBI-3424, which selectively releases a potent DNA-alkylating antitumor agent in the presence of the aldo-keto reductase 1C3 (AKR1C3) enzyme that is highly expressed in tumors. Additional information can be found at www.obipharma.com.GlycOBI®, EndoSymeOBI®, ThiOBI® and HYPrOBI®are registered trademarks of OBI Pharma. Obrion™ and GlycOBI DUO™ are trademarks under registration.1 National Institute of Health for Rare Diseases. Sept. 2025https://rarediseases.info.nih.gov/diseases/9304/cholangiocarcinoma2 US FDA website. Designating an Orphan Product: Drugs and Biological Products Sept.25 https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-productsForward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Kevin Poulos, Chief Business OfficerOBI Pharma USA, Inc.+1 (619) 537 7698, ext. 102kpoulos@obipharma.comSOURCE: OBI Pharma USA, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

JCN Newswire

Mitsubishi Shipbuilding Delivers Large Car Ferry KEYAKI to Shin Nihonkai Ferry and Japan Railway Construction, Transport and Technology Agency

The KEYAKITOKYO, Nov 17, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Shipbuilding Co., Ltd., a part of Mitsubishi Heavy Industries (MHI) Group, delivered the large car ferry KEYAKI, produced for Shin Nihonkai Ferry Co., Ltd. and Japan Railway Construction, Transport and Technology Agency (JRTT), at the Enoura Plant of MHI's Shimonoseki Shipyard & Machinery Works in Yamaguchi Prefecture on the 11th. The new ferry will serve on a shipping route between the cities of Otaru in Hokkaido and Maizuru in Kyoto Prefecture from the 14th.The KEYAKI is the first ferry in Japan to adopt the latest energy-saving hull form, including a KATANA BOW and buttock-flow stern hull(Note1) with ducktail(Note2). Propulsion resistance is suppressed by an energy-saving roll-damping system combining an anti-rolling tank(Note3) and fin stabilizers(Note4). Together these innovations enable a 5% savings in energy compared to earlier vessels.The interior of the ferry features open spaces including a three-story atrium at the entrance, elevators with clear walls and doors, and a forward salon with a two-story atrium. There is an open-air bath on the top deck and a multipurpose room for enjoying a variety of activities. A variety of cabins are available to provide maritime travel experiences that meet various needs.Going forward, Mitsubishi Shipbuilding will continue to contribute to active use of sea transport and environmental protection, resolving diverse issues together with its business partners through construction of ferries that provide stable sea transport together with outstanding energy and environmental performance.1A hull design that reduces water resistance by optimizing the shape of the stern.2A hull form with the stern protruding like a duck's tail.3An anti-rolling tank contains water that shifts laterally within a ship's beam. When a vessel rolls, the tank water moves in the direction opposite to the rolling, easing the rolling effect.4Fin stabilizers are another device that reduces ship rolling. Attached to both sides of the hull, these movable fins generate lifting power in the water in the direction opposite to the rolling.Main Specifications of the KEYAKIShip typePassenger-carrying car ferryLOA199mBeam25.5mGross tonnage14,157tService speed28.3 knotsPassengers286CapacityApprox. 150 trucks and 30 passenger cars About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

ACN Newswire

OBI-902获美国FDA审核通过用于治疗胆管癌的“孤儿药”资格认定

台北，台湾, 2025年11月17日 - (亚太商讯 via SeaPRwire.com) - 浩鼎（4174.TWO）宣布，收到美国食品药品监督管理局（US FDA）通知，其TROP2靶向ADC新药OBI-902已获准用于治疗胆管癌（Cholangiocarcinoma）的“孤儿药（Orphan Drug Designation）”资格认定。OBI-902为浩鼎自主研发、采用糖位点特异性偶联技术的新型ADC。胆管癌是一种罕见且致死率高的恶性肿瘤，在美国的患者人数少于五万人。根据疾病分期、组织类型及发病部位不同，其五年生存率约为2%至23%¹。目前，美国FDA尚未批准任何用于胆管癌的ADC药物上市销售。为鼓励企业开发治疗罕见疾病的新药，美国FDA设立了“孤儿药”资格认定制度。符合条件的潜在新药经审核通过后，可获得多项政策支持，包括临床支出税务优惠、注册申请费用减免，以及市场独占期等²。在美国，罕见疾病被定义为患者人数少于二十万人的疾病。浩鼎已于2025年8月在美国及台湾启动OBI-902 I/II期临床试验，招募晚期实体瘤患者，旨在评估该药物的安全性、药代动力学特征及初步疗效。浩鼎首席执行官王慧君博士表示：“基于临床前研究，OBI-902相比已上市或研发中的其他TROP2 ADC展现了多项优势，包括在血液循环中具有高稳定性、具备对周围未表达TROP2癌细胞的杀伤能力（旁观者效应），并具备克服耐药性的潜力。在动物试验和类器官肿瘤模型中均表现出优异的药物活性。更重要的是，这是浩鼎首次在临床上应用独家专利GlycOBI® ADC关键技术，其中包含胆管癌患者。我们期待临床试验进一步证实OBI-902具备成为同类最佳（best-in-class）的潜力。”About OBI-902OBI-902 是一款以 TROP2 为靶向的抗体-药物偶联物（ADC）新药，携带强效拓扑异构酶 I 抑制剂用于杀伤肿瘤细胞，药物抗体比例（Drug-Antibody Ratio, DAR）为 4。TROP2 在乳腺癌、肺癌、胆道癌（胆管癌）、卵巢癌、胃癌等多种实体瘤中均呈高表达，被视为理想的抗癌靶点。OBI-902 采用浩鼎专利 GlycOBI® 糖位点特异性技术，具备良好的稳定性和亲水性。在多种动物模型中显示出显著的抗肿瘤功效、良好的安全性及优异的药代动力学特性。其临床试验申请（IND）已于 2025 年 4 月 30 日获美国 FDA 批准。浩鼎于 2021 年 12 月自博奥信生物技术公司（Biosion, Inc., www.biosion.com）引进 TROP2 抗体。根据合约条款，博奥信保留该抗体在中国境内的相关权利。除中国境内抗体权利外，浩鼎拥有 OBI-902 的全球商业化权利。About GlycOBI®浩鼎开发的 GlycOBI® 糖位点特异性 ADC 技术已应用至临床阶段，具备“即插即用”特性，可兼容多种抗体、连接子（linkers）和药物（payloads），其 DAR 可高达 16。透过自主研发的双功能酶 EndoSymeOBI® 及高亲水性连接子技术 HYPrOBI®，可在 GMP 工艺下高效量产均一化 ADC。该偶联过程可避免破坏抗体结构，同时确保 ADC 具备与天然抗体相似的生物特性。HYPrOBI® 高亲水性连接子可提高偶联效率、降低生产过程中不均匀聚集风险，使 ADC 制程具更高优势。多项动物实验显示，采用 GlycOBI® 偶联的 ADC 在抗肿瘤活性与稳定性上均优于传统 ADC。GlycOBI®、EndoSymeOBI® 和 HYPrOBI® 属于浩鼎 Obrion™ ADC 专利技术组合的一部分，另包含 ThiOBI® 与 GlycOBI DUO™。OBI-902 为首款采用 Obrion™ ADC 关键技术进入临床评估的新药，目前已在美国及台湾开展 I/II 期临床试验，以评估其在癌症治疗中的安全性和疗效。About OBI Pharma浩鼎（OBI Pharma, Inc.）成立于 2002 年，总部位于台湾，是一家产品已进入临床阶段的全球肿瘤新药研发公司。浩鼎及其全资子公司 OBI Pharma USA, Inc. 的使命，是研发创新抗癌药物，为具有高度未满足医疗需求的患者提供新的治疗选择。浩鼎的研发核心聚焦于新型抗体-药物偶联物（Antibody-Drug Conjugates, ADC），包括第一代半胱氨酸偶联 TROP2 ADC：OBI-992。通过专利 ADC 关键技术 GlycOBI®，结合 EndoSymeOBI® 和 HYPrOBI®，浩鼎已建立下一代 ADC 产品布局，包括：单抗 ADC：OBI-902（TROP2）、OBI-904（Nectin-4）双抗单药 ADC：HER2 × TROP2双抗双药 ADC：cMET × HER3为拓展 HYPrOBI® 在连接子领域的应用范围，浩鼎进一步开发新型 ThiOBI® 平台，实现不可逆的半胱氨酸偶联能力。此外，浩鼎产品线亦包含全球首创 AKR1C3 靶向小分子前药 OBI-3424，该药物可在肿瘤中过表达的醛酮还原酶（AKR1C3）作用下选择性释放强效 DNA 烷基化剂以治疗癌症。更多信息请参阅： www.obipharma.com 。GlycOBI®、EndoSymeOBI®、ThiOBI® 和 HYPrOBI® 为浩鼎注册商标。Obrion™ 与 GlycOBI DUO™ 为申请中商标。1 National Institute of Health for Rare Diseases. Sept. 2025https://rarediseases.info.nih.gov/diseases/9304/cholangiocarcinoma2 US FDA website. Designating an Orphan Product: Drugs and Biological Products Sept.25 https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products媒体联系：陈祈宏 Derek Chen公共事务部 负责人 | Head of Public Affairs台灣浩鼎（OBI Pharma, Inc.）M: +886-939-797-803 | T: +886-2-2655-8799 Ext. 223derekchen@obipharma.com Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

SuperX AI Technology Limited任命企业科技资深领军人物黄陈宏博士为董事局主席兼CEO 加速全球AI基础设施布局

新加坡, 2025年11月17日 - (亚太商訊) - SuperX AI Technology Limited (纳斯达克: SUPX)（简称"SuperX"或"公司"），一家全栈式 AI 基础设施解决方案提供商，今日宣布任命黄陈宏博士为公司董事局主席、执行董事兼首席执行官，该任命自 2025 年 12月 1 日起生效。随着全球 AI 计算需求的持续增长，企业对集成化、高能效的基础设施解决方案需求激增。此次任命正值SuperX发展的重要阶段，公司将继续推进其全球扩张工作。董事会相信，经验丰富的领导层将支持公司执行其战略优先事项的能力。这一战略性任命标志着SuperX在成为全球人工智能基础设施领导者的征程中迈出了关键一步。此举不仅为公司带来了黄博士数十年的高管领导经验，同时也将加强其经营管理和公司治理。此次委任旨在通过黄博士卓越的领导力和深厚的行业积淀，加速推进公司构建全球化的全栈式模块化AI工厂的宏伟蓝图。在此之前，公司也于2025年11月11日任命Frank Han为执行董事，以及Roy Rong为独立董事。Frank Han曾任黑石集团资深合伙人，此前还曾在凯雷集团美国收购部、高盛亚洲特殊情况部和麦肯锡公司任职。Roy Rong目前担任TikTok及全球职能部门的财务业务合作伙伴负责人。他曾担任魔古科技（纽约证券交易所代码：MOGU）和车车集团（纳斯达克代码：CCG）的独立董事和审计委员会主席，并在Yixia Technology Co., Ltd.、Quixey Inc.、UC Web、乡村基（中国）餐饮管理有限公司（纽约证券交易所代码：CCSC）、谷歌、Soletron和Sibel Systems等公司担任首席财务官和财务管理职务。黄陈宏博士：引领SuperX开启AI基础设施新篇章的资深领航者黄陈宏博士是一位资深的企业技术领袖，拥有三十年成功领导并扩展跨国公司各类主营业务的辉煌经验。他的加入，是SuperX为提升战略执行、实现全球扩张而做出的极具前瞻性的决策，与SuperX构建端到端AI基础设施的使命深度契合。规模化复杂技术运营的卓越专长：黄博士曾担任SAP全球执行副总裁兼大中华区总裁，以及戴尔大中华区董事长兼总裁，成功管理和扩展了全球最复杂的企业技术业务。该经验使他深谙如何在全球范围内构建和管理高度复杂的运营体系。SuperX致力于打造一个覆盖全球的"AI工厂"蓝图，这一前所未有的挑战，正是黄博士多年积累的规模化运营经验和卓越领导力的用武之地。他也将引领SuperX在全球范围内高效、有序地推进AI基础设施的部署，期望为公司带来可预见的规模效应和增长回报。深厚的数据中心基础设施与电源方案专业背景： 在担任施耐德电气旗下APC大中华区总裁期间，黄博士积累了数据中心电力和冷却基础设施领域的关键实践经验和专业知识。这对于SuperX而言至关重要，因为高性能AI的基石正是稳定、高效的基础设施，特别是其专有的液冷解决方案。黄博士的专业背景将帮助SuperX优化其核心技术，确保为客户提供绿色、高性价比的计算能力。核心网络与技术能力的坚实根基： 黄博士早期在Tellabs和北电网络（Nortel Networks）的任职经历，赋予了他深厚的网络技术功底和管理经验。这将为他领导SuperX这家植根于"硬件+软件+服务"全栈模式的公司奠定坚实基础，确保公司在技术创新和整合方面保持优势。黄陈宏博士表示： "我非常荣幸能在AI的黄金时代领导SuperX。当前市场需求正迅速从单一组件转向集成化、端到端且能快速大规模部署的解决方案——我们将其定义为‘AI工厂’。SuperX拥有清晰的战略愿景和具有颠覆性的集成技术。我的首要任务是聚焦运营执行，加速我们全栈AI基础设施的全球部署，将SuperX打造成为AI基础建设领域当之无愧的全球领导者，为股东创造长期可持续的价值。"黄陈宏博士简介黄陈宏博士是一位经验丰富的技术高管，拥有超过30年的全球企业软件、云计算和IT基础设施公司领导经验。自2025年4月起，他担任中国领先的企业软件公司用友的董事会成员，此前于2025年1月至3月担任该公司总裁。在此之前，黄博士于2021年8月至2024年12月担任SAP全球执行副总裁兼大中华区总裁，期间他负责推动云业务收入的显著增长。2014年10月至2021年8月，他担任戴尔大中华区董事长兼总裁，指导戴尔在该地区的业务拓展，并领导了EMC收购后的整合工作。黄博士早年曾在施耐德电气旗下的APC公司、泰乐公司和北电网络公司担任高级领导职务，包括APC大中华区总裁、珠海Uniflair董事长、泰乐中国区总裁以及北电网络中国区运营商销售总裁。黄博士拥有德克萨斯农工大学电气工程博士学位、复旦大学硕士学位和复旦大学物理学学士学位。黄博士是美国公民。关于SuperX AI Technology Limited（纳斯达克代码：SUPX）SuperX AI Technology Limited 是一家人工智能基础设施解决方案提供商，为人工智能数据中心提供全面的产品组合，包括专有硬件、先进软件以及端到端的服务。公司的服务涵盖先进的解决方案设计与规划、高性价比的基础设施产品集成，以及端到端的运营与维护。其核心产品包括高性能AI服务器、800伏直流（800VDC）解决方案、高密度液冷解决方案，以及AI云和AI智慧体。公司总部位于新加坡，为全球的机构客户提供服务，包括大型企业、研究机构、云及边缘计算部署等。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

15th Asian Logistics, Maritime and Aviation Conference opens today

- The 15th Asian Logistics, Maritime and Aviation Conference (ALMAC) opened today under the theme “Collaboration and Growth in the New Trade Landscape”- The event brings together over 80 heavyweight speakers to explore industry trends and opportunities, driving high-quality development in logistics and supply chain management-  New thematic sessions spotlight the Middle East and Central Asia markets, with speakers sharing the latest developments and future opportunities, analysing key strategies and investment directions- John Lee, Chief Executive of the HKSAR, and Almaz Turgunbaev, Deputy Minister of Transport and Communications of the Kyrgyz Republic, attended the Special Address session on the first day of the conference. Their participation aims to deepen international exchange and cooperation, helping to further enhance Hong Kong’s position as an international shipping and aviation hub and its roles as a “superconnector” and “super value-adder”.HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – The 15th Asian Logistics, Maritime and Aviation Conference (ALMAC), organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council (HKTDC), opened today (17 November) and runs for two days at the Hong Kong Convention and Exhibition Centre. Under the theme “Collaboration and Growth in the New Trade Landscape”, the conference aligns with recommendations in the 15th Five-Year Plan to enhance Hong Kong’s status as an international shipping centre, and policies laid out in the Policy Address to strengthen the development of the shipping, aviation and logistics sectors in the city. As the industry’s annual flagship event, the two-day conference gathers over 80 distinguished speakers, including government officials and industry leaders, to discuss trends and opportunities and promote high-quality development in logistics and supply chain management.John Lee, Chief Executive of the HKSAR, attended the first day of the conference to deliver a Special Address. In addition, this year’s ALMAC invited Central Asian official Almaz Turgunbaev, Deputy Minister of Transport and Communications of the Kyrgyz Republic, to also deliver a Special Address.John Lee said: “The conference theme this year, ‘Collaboration and Growth in the New Trade Landscape’, is a timely response to rising geopolitical tensions and the volatile global trade policies, which present considerable challenges for our maritime, aviation and logistics industries, from route planning and shipping fleet deployment to inventory and warehouse management. Nevertheless, as the Chinese saying goes, ‘where there are challenges, there are opportunities’. Geopolitical risks can be overcome by market diversification. Increased costs related to supply chain concerns can be offset, at least partially, by technology-enabled efficiencies.”Mr Lee also shared: “I am particularly pleased to announce that Hong Kong has established Partner Port relationships with Guangxi port and Dalian port in the Chinese Mainland, and Port San Antonio in Chile. These ports are of strategic importance, and true to our character and policy priorities. As an international maritime centre, we connect the Chinese Mainland with the world and seek partners who support an open, international trade order.”In her welcome remarks, Sophia Chong, Executive Director of the HKTDC, said: “Now is the perfect time to embrace new possibilities, as trade networks and supply chains around the world undergo a sweeping transformation. The ever-changing trade polices of major economies continue to keep business agile. At the same time, the world is being rapidly reshaped by technological advances – particularly the digitalisation of trade – and a growing industry-wide commitment to sustainability.  Hong Kong, as a major hub for aviation, shipping, logistics and supply chain management, is at the forefront of these changes. The HKTDC remains committed to leveraging the city’s unique strengths to help businesses establish resilient and sustainable supply chains, while reinforcing Hong Kong’s role as a superconnector and super value-adder.”Strengthening Hong Kong’s logistics hub role and promoting regional cooperationRecommendations in the 15th Five-Year Plan to support the consolidation and enhancement of Hong Kong’s status as an international shipping centre carry profound strategic significance. The HKTDC will continue to deepen Hong Kong’s role as an international exchange platform, facilitating connections and substantive cooperation between local and overseas industries, assisting enterprises in “going global”, helping to expand their businesses in global markets, and enhancing their competitiveness. A key focus is promoting trade linkages and actively encouraging enterprises to leverage the HKTDC’s trade platforms and events to achieve greater cooperation across industries. This year’s ALMAC continues to feature business-matching sessions, connecting shippers with service providers to foster regional partnerships and drive industry growth.ALMAC this year features exhibition zones dedicated to aviation, the low-altitude economy, technology, supply chain management and logistics services as well as maritime and port services. Over 90 exhibitors are showcasing the latest leading logistics and supply chain solutions. Notably, the Low-altitude Economy zone makes its debut at ALMAC, with enterprises from the Regulatory Sandbox pilot projects – including SF Express (Hong Kong) and Esri China (Hong Kong) Limited –demonstrating cutting-edge technologies and applications in drones, unmanned aerial vehicles (UAVs) and urban air mobility (UAM), promoting awareness of the latest innovations and applications in this fast-rising sector.Three key trends in focus; unlocking opportunities in the Middle East and Central AsiaThis year’s ALMAC focuses on three key trends: supply chain diversification, sustainability and green energy and innovation and technology, highlighting Hong Kong’s critical role in global connectivity.On the first day, the key session “Insights into a New Era of Global Trade: Driving Business Growth” will feature international industry leaders from SEKO Logistics, GEODIS, and Mattel who will explore the challenges and opportunities arising from changes in trade policies and economic fragmentation. Newly launched thematic sessions will focus on the potential of the Middle Eastern and Central Asian markets. In the Middle East Session, representatives from Etihad Airways, DP World Logistics and the Qatar Free Zones Authority will share insights on logistics innovation and investment strategies. The Central Asia Session will engage representatives from QazTrade Center for Trade Policy Development, JSC, under the Ministry of Trade and Integration of the Republic of Kazakhstan, Shyngar Trans Logistics Company, the Organisation for Economic Co-Operation and Development and PTC. The discussion will address regional supply chain development and the advantages of multimodal transport.Low-altitude economy and smart ports: reshaping the air and maritime transport landscapeIn the first-day session “The Engine of Low-altitude Economy: How Cargo Drones Are Revolutionising the Future of Air Logistics”, Manal Habib, CEO and Founder, MightyFly; Bobby Healy, CEO and Founder, Manna; Kenny Lau, Chief Technology Officer, SF Express (Hong Kong) Limited; Ryan Walsh, Founder and CEO, Valqari; and Andrea Wu, CEO, Urban-Air Port Ltd, shared the latest breakthroughs in drone freight design, automation and AI-driven logistics systems. Meanwhile, the Low-altitude Economy zone at the conference is showcasing drones and related applications, allowing participants to experience first hand the future of air transport and explore the potential of low-altitude economy innovations in the logistics sector.In addition, the Port Community System X LSCM Maritime Summit 2025 will focus on the future development of smart ports and smart trade. The summit will explore how applying the Port Community System (PCS) can significantly enhance operational efficiency and supply chain visibility through cutting-edge technologies such as AI, blockchain and the Internet of Things. It will also showcase Hong Kong’s unique advantages as an international shipping centre and a hub for smart trade. Conference and workshops support enterprises’ green transformationA first-day workshop, “Sustainable Finance: Navigating a Sustainable Future across Logistics, Shipping, and Aviation Industries”, focused on how ESG (environmental, social and governance) is reshaping operational models and development directions in the logistics, maritime and aviation sectors. Patrick Lau, Deputy Executive Director of the HKTDC, gave the Opening Address at the workshop, followed by industry experts including KT Ting, Chief Operating Officer, Hong Kong Quality Assurance Agency; Calvin Chung, Director, Chimbusco Pan Nation; Wai Yeung Tam, Senior Finance Manager, SF REIT Asset Management Limited; and Eric Liu, Chief Executive, Cathay United Bank Hong Kong Branch. They discussed challenges and opportunities in the industry’s green transformation and addressed the important role of sustainable finance to support enterprises in the transition.As the world strives towards net-zero emissions, Hong Kong is committed to developing as a green maritime centre. The recent Policy Address proposes establishing Hong Kong as a green marine fuel bunkering centre, focusing on green methanol, green ammonia and hydrogen. A session titled “Green Energy Forum: Fuels, Freight, and the Road to Net Zero” will be held tomorrow (18 November) to share pathways, challenges and opportunities for a more sustainable and low-carbon future. Speakers include Essam Al Sheibany, Vice President Sustainability, Asyad Group; Tryggvi Thor Herbertsson, Head of Hydrogen Strategy and Partnership, Qair Group; James Laybourn, Regional Segment Director, APAC, DNV Energy Systems; and Wu Yi, Deputy General Manager, Kunlun Energy Co., Ltd.ALMAC offers a rich and diverse programme for participants, with tomorrow’s highlighted sessions, including the Hong Kong Authorized Economic Operator (AEO) Programme, the Supply Chain Management and Logistics Panel, “Logtech Forum: Stay Ahead in the Next Wave of Supply Chain Innovation”, and the Youth Empowerment Workshop. Representatives from companies such as HP, Reckitt, DHL Express, LALAMOVE and Procter & Gamble will share valuable insights and practical skills, helping participants stay ahead of the latest industry developments.The 15th Asian Logistics, Maritime and Aviation ConferenceDate17 and 18 November 2025 (Monday and Tuesday)VenueHall 3FG, HKCECWebsitesALMAC: https://almac.hktdc.com/conference/almac/enProgramme: https://almac.hktdc.com/conference/almac/en/programmeSpeaker list: https://almac.hktdc.com/conference/almac/en/speakerPhoto download: https://bit.ly/4ojiKsFThe 15th Asian Logistics, Maritime and Aviation Conference (ALMAC), organised by the HKSAR Government and the HKTDC, opened today. Under the theme “Collaboration and Growth in the New Trade Landscape”, the event brings over 80 heavyweight speakers to explore industry trends and opportunitiesJohn Lee, Chief Executive of the HKSAR, attended the first day of the conference to deliver a Special AddressSophia Chong, Executive Director of the HKTDC, delivered welcome remarks at the Opening SessionBusiness-matching sessions at ALMAC are connecting shippers with service providers to foster regional partnerships and drive industry growthThe Low-altitude Economy zone made its debut at this year’s ALMAC Exhibition, demonstrating cutting-edge technologies and applications in drones, unmanned aerial vehicles and urban air mobilityThe session titled “Steering Business Growth in a New Era of Global Trade” explored the ripple effects of evolving trade policies and the impact of rising economic fragmentationIn the session “Tapping the Middle East: Logistics, Innovation & Trade Potentials”, industry leaders from the Middle East shared the huge opportunities and transformation potential in logistics and supply chainsMedia enquiriesYuan Tung Financial Relations:Louise SongTel: (852) 3428 5690Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Johnny TsuiTel: (852) 2584 4395Email: johnny.cy.tsui@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

Focus Graphite Commissions WSP to Complete Air Dispersion Modelling and Dust Management Plan at Lac Knife

The updated study incorporates redesigned dry-stack tailings system engineered to eliminate acid mine drainage and is one of the final ESIA reports.Ottawa, Ontario--(ACN Newswire via SeaPRwire.com - November 17, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading Canadian graphite developer advancing high-grade projects, is pleased to announce that it has commissioned an updated Air Dispersion Modelling and Dust Management Study (the "Study") for its 100%-wholly owned Lac Knife Project (the "Project") in Quebec. This work represents one of the final environmental studies required to complete the Environmental and Social Impact Assessment ("ESIA") and advance the Project toward mine-permitting readiness.The Study will be led by WSP Canada Inc. ("WSP"), a world-leading Montreal-based global engineering, environmental, and professional-services consultancy, and will be conducted under the supervision and management of IOS Geosciences Inc. ("IOS"), the Company's geological consultant and general contractor for the Project. WSP includes the former Woods Engineering, which participated in the 2019 preliminary design of the dry-stack tailings storage facility ("TSF"), as well as Golder Inc., which conducted the original 2014 Study.The Study will evaluate the potential airborne dispersion of dust and gases associated with mining operations, including:wind-driven erosion from the TSF,emissions generated by blasting activities, andtraffic-related dust along the 7-kilometre access road linking Lac Knife to Highway 389.This updated modelling replaces the earlier 2014 study to reflect the re-engineered dry-stack tailings design, developed as part of the 2021 Feasibility Study (the "Feasibility") update. The redesign eliminates the former wet-pond configuration and instead utilizes dolomitic marble to amend and encapsulate tailings, thereby preventing acid mind drainage ("AMD") and metal leaching. This new TSF concept was considered material enough to necessitate remodelling of the areal dispersion.The current program directly addresses follow-up questions from Quebec's Ministry of Sustainable Development, Environment, and the Fight Against Climate Change ("MDDELCC"), issued during its review of the Company's 2014 ESIA submission. Results from the Study are expected by February 2026, aligning with the planned submission of the final revised ESIA."The completion of the air dispersion modelling and dust management plan marks one of the last major technical steps in our environmental review process," said Dean Hanisch, Chief Executive Officer of Focus Graphite. "We are now systematically finalizing outstanding ESIA components to move Lac Knife toward the permitting stage. Each of these studies reflects our ongoing commitment to advance the Project responsibly."Qualified PersonThe technical content disclosed in this news release was reviewed and approved by Rejean Girard, P.Geo. (QC), President of IOS Geosciences Inc., a consultant to the Company, and a qualified person as defined under National Instrument NI-43-101.About WSP Canada Inc.WSP Canada Inc. is a Canadian subsidiary of WSP Global Inc., one of the world's leading professional-services firms. Headquartered in Montreal, Quebec, WSP provides multidisciplinary engineering, environmental, and consulting services across the infrastructure, energy, mining, transportation, and built-environment sectors. With thousands of professionals across Canada and internationally, WSP delivers technical excellence and sustainable solutions supporting clients through every stage of project development.For more information on WSP Canada Inc. please visit https://www.wsp.com/en-ca/ About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Focus Graphite's flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Focus Graphite's Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, they go beyond mining – we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Focus Graphite's commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals – reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.comLinkedIn: https://www.linkedin.com/company/focus-graphite/ X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things, the anticipated timing, scope, and results of the Air Dispersion Modelling and Dust Management Study (the "Study") at the Lac Knife Project; the completion of the Company's Environmental and Social Impact Assessment ("ESIA") and related technical studies, including hydrogeological and tailings dam analyses; the expected timing of regulatory submissions and approvals; the potential for the Project to achieve mine-permitting readiness; and the advancement of the Lac Knife Project toward development. Forward-looking information also includes statements regarding the Company's expectations concerning the effectiveness of the redesigned dry-stack tailings storage facility, the ability to meet Québec's environmental and regulatory standards, the anticipated role of the Lac Knife and Lac Tetepisca projects within Canada's Critical Minerals Strategy, and the Company's capacity to secure the financing and partnerships required to advance these projects responsibly and sustainably.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274738 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com